AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Gougeon, ML Rouzioux, C Liberman, I Burgard, M Taoufik, Y Viard, JP Bouchenafa, K Capitant, C Delfraissy, JF Levy, Y
Citation: Ml. Gougeon et al., Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients, AIDS, 15(13), 2001, pp. 1729-1731

Authors: Bocchino, M Ledru, E Debord, T Gougeon, ML
Citation: M. Bocchino et al., Increased priming for interleukin-12 and tumour necrosis factor alpha in CD64 monocytes in HIV infection: modulation by cytokines and therapy, AIDS, 15(10), 2001, pp. 1213-1223

Authors: Lecoeur, H Prevost, MC Gougeon, ML
Citation: H. Lecoeur et al., Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: A reconsideration of the specificity of the annexin V/Propidium iodide assay, CYTOMETRY, 44(1), 2001, pp. 65-72

Authors: Lecoeur, H Fevrier, M Garcia, S Riviere, Y Gougeon, ML
Citation: H. Lecoeur et al., A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity, J IMMUNOL M, 253(1-2), 2001, pp. 177-187

Authors: Chami, M Gozuacik, D Lagorce, D Brini, M Falson, P Peaucellier, G Pinton, P Lecoeur, H Gougeon, ML le Maire, M Rizzuto, R Brechot, C Paterlini-Brechot, P
Citation: M. Chami et al., SERCA1 truncated proteins unable to pump calcium reduce the endoplasmic reticulum calcium concentration and induce apoptosis, J CELL BIOL, 153(6), 2001, pp. 1301-1313

Authors: Fellay, B Chofflon, M Juillard, C Paunier, AM Landis, T Roth, S Gougeon, ML
Citation: B. Fellay et al., Beneficial effect of co-polymer 1 on cytokine production by CD4 T cells inmultiple sclerosis, IMMUNOLOGY, 104(4), 2001, pp. 383-391

Authors: Chami, M Gozuacik, D Saigo, K Capiod, T Falson, P Lecoeur, H Urashima, T Beckmann, J Gougeon, ML Claret, M le Maire, M Brechot, C Paterlini-Brechot, P
Citation: M. Chami et al., Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis, ONCOGENE, 19(25), 2000, pp. 2877-2886

Authors: Gougeon, ML Poccia, F Boullier, S
Citation: Ml. Gougeon et al., Human gamma delta T lymphocytes in HIV disease: effector functions and control by natural killer cell receptors, SPR SEM IMM, 22(3), 2000, pp. 251-263

Authors: Malkovsky, M Wallace, M Fournie, JJ Fisch, P Poccia, F Gougeon, ML
Citation: M. Malkovsky et al., Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: gamma delta T lymphocytes and natural killer cells, AIDS, 14, 2000, pp. S175-S186

Authors: Gougeon, ML
Citation: Ml. Gougeon, How does programmed cell death contribute to AIDS pathogenesis?, HANDB EXP P, 142, 2000, pp. 127-150

Authors: Michel, P Balde, AT Roussilhon, C Aribot, G Sarthou, JL Gougeon, ML
Citation: P. Michel et al., Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: Correlation of T cell apoptosis with beta(2) microglobulin concentration and disease evolution, J INFEC DIS, 181(1), 2000, pp. 64-75

Authors: Ledru, E Christeff, N Patey, O de Truchis, P Melchior, JC Gougeon, ML
Citation: E. Ledru et al., Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome, BLOOD, 95(10), 2000, pp. 3191-3198

Authors: Naora, H Gougeon, ML
Citation: H. Naora et Ml. Gougeon, Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression, CELL DEAT D, 6(10), 1999, pp. 1002-1011

Authors: Gougeon, ML Boullier, S Colizzi, V Poccia, F
Citation: Ml. Gougeon et al., NKR-mediated control of gamma delta T-cell immunity to viruses, MICROBES IN, 1(3), 1999, pp. 219-226

Authors: Brown, L Souberbielle, BE Marriott, JB Westby, M Desselberger, U Kaye, T Gougeon, ML Dalgleish, A
Citation: L. Brown et al., The conserved carboxy terminal region of HIV-1 gp120 is recognized by seronegative HIV-exposed people, AIDS, 13(18), 1999, pp. 2515-2521

Authors: Christeff, N Melchior, JC de Truchis, P Perronne, C Nunez, EA Gougeon, ML
Citation: N. Christeff et al., Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations, AIDS, 13(16), 1999, pp. 2251-2260

Authors: Naora, H Gougeon, ML
Citation: H. Naora et Ml. Gougeon, Enhanced survival and potent expansion of the natural killer cell population of HIV-infected individuals by exogenous interleukin-15, IMMUNOL LET, 68(2-3), 1999, pp. 359-367

Authors: Gougeon, ML Lecoeur, H Sasaki, Y
Citation: Ml. Gougeon et al., Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART), IMMUNOL LET, 66(1-3), 1999, pp. 97-103

Authors: Poccia, F Battistini, L Cipriani, B Mancino, G Martini, F Gougeon, ML Colizzi, V
Citation: F. Poccia et al., Phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes suppress in vitrohuman immunodeficiency virus type 1 replication by cell-released antiviralfactors including CC chemokines, J INFEC DIS, 180(3), 1999, pp. 858-861

Authors: Naora, H Gougeon, ML
Citation: H. Naora et Ml. Gougeon, Activation, survival and apoptosis of CD45RO(+) and CD45RO(-) T cells of human immunodeficiency virus-infected individuals: effects of interleukin-15and comparison with interleukin-2, IMMUNOLOGY, 97(2), 1999, pp. 181-187

Authors: Boullier, S Poquet, Y Debord, T Fournie, JJ Gougeon, ML
Citation: S. Boullier et al., Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the V gamma 9V delta 2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons, EUR J IMMUN, 29(1), 1999, pp. 90-99

Authors: Pollicino, T Terradillos, O Lecoeur, H Gougeon, ML Buendia, MA
Citation: T. Pollicino et al., Pro-apoptotic effect of the hepatitis B virus X gene, BIOMED PHAR, 52(9), 1998, pp. 363-368
Risultati: 1-22 |